SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending due to recent analyst upgrades from Jefferies and Wedbush, highlighting its growing commercial traction in quantum annealing and a dual roadmap. The community is actively debating whether these are legitimate catalysts or orchestrated pumps, especially with the company preparing to showcase practical quantum applications at CES 2026. This discussion reflects broader market sentiment regarding the future and valuation of the nascent quantum computing sector.

Starfighters Space Inc

Starfighters Space Inc. (FJET) is a highly discussed recent IPO, actively trending amidst the broader strength in the space sector. Community sentiment points to significant speculative interest driven by its low float and perceived short squeeze potential, leveraging its unique position in commercial supersonic aircraft for payload delivery. While bulls envision substantial upside, others express caution regarding financials and the company's operational model, contributing to its notable volatility.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining is experiencing a surge in conversation following reports of pivotal high-grade silver drill results from its Vortex system. This news, coupled with continued major investments from figures like Eric Sprott and a broader bullish outlook for precious metals, is driving strong community excitement and speculation about the company's substantial future potential, notably drawing comparisons to prior discussions surrounding AMC's investment.

Jyong Biotech Ltd. operates as a holding company, which engages in the development of biotechnology products. It offers plant-derived drugs that focus on the treatment of urinary system diseases. The company was founded by Fu Feng Kuo in July 2002 and is headquartered in New Taipei, Taiwan.

Jyong Biotech Ltd.

Jyong Biotech (MENS) is gaining significant attention following positive Phase II clinical trial results for its prostate cancer drug, MCS-8, generating strong bullish sentiment among traders. The stock is experiencing extreme volatility and frequent trading halts, prompting discussions about its low float characteristics and the potential for a continued speculative surge, although some express concerns about its rapid price action.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is a major trending topic as its shares experienced significant pressure following its recent earnings report, despite some estimate beats, driven by investor concerns over persistent weakness in Greater China sales and ongoing margin compression from tariffs. The community is heavily split, with many viewing the drop as an oversold opportunity for a long-term rebound, while others highlight increasing competition and management challenges. Technical analysis is a major talking point as traders debate if the iconic brand can "Just Do It" and find a bottom.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is a central topic of discussion due to its accelerated satellite deployment cadence, with the BlueBird 6 mission and BlueBird 7's transit to Cape Canaveral creating significant buzz. Bulls anticipate substantial gains and a potential short squeeze, emphasizing AT&T's integration of satellite-to-device connectivity and the company's unique technology. However, a vocal bearish faction highlights elevated valuation concerns and the inherent risks associated with space launches, creating a polarized sentiment within the burgeoning space sector.

Amprius Technologies, Inc. engages in the development, manufacture, and market lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the United States and Rest of the World geographical segments. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is trending following its strategic CEO transition, as President Tom Stepien, with extensive operational experience, takes the helm from founder Dr. Kang Sun, who remains an executive advisor. This leadership change, alongside the expansion of its South Korea Battery Alliance and integration into Nokia Drone Networks, fuels community optimism for significant production scale-up and future contracts in the high-demand drone and electric aviation sectors.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is experiencing strong upward momentum driven by a major new contract to build missile-tracking satellites for the U.S. Space Development Agency, cementing its position as a key national security space prime. This significant win, coupled with a highly successful year of Electron launches, has sparked widespread bullish sentiment within the community, with many anticipating continued growth for the company and the broader space sector.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending due to its planned merger with fusion energy company TAE Technologies, igniting a debate between bulls excited about the long-term potential of clean energy and skeptics who view the tie-up as highly speculative. The community is actively discussing whether this move represents a transformative step into cutting-edge technology or another instance of a strategy to attract investor interest amidst ongoing financial challenges.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. It offers Alpha, Beta, Gamma, and orbital transfer vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 27, 2017 and is headquartered in Cedar Park, TX.

Firefly Aerospace Inc.

Firefly Aerospace is trending due to its recent inclusion in the Russell 2000 and 3000 indexes, supported by an encouraging earnings report and the strategic acquisition of SciTec. The community is actively discussing its perceived undervaluation relative to its initial public offering, highlighting its successful lunar mission and strong potential for significant defense contracts, particularly the anticipated "Golden Dome" initiative. These developments, alongside resolved technical hurdles and broader market interest in the space sector, are fueling increased conversation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$BVAXF has some impressive partners and portfolio after the recent acquisition.   
 
I can&#39;t imagine this company not being a prime candidate for buyout in the next twelve months.  With 250-275 million shares (including outstanding warrants), below is what buyout prices per share in US dollars is: 
 
Levels that are a joke IMO 
100 million BO is 40 cents a share 
250 million BO is $1 a share 
500 million BO is $2 a share 
 
Realistic Levels 
750 million BO is $3 a share 
1 Billion BO is $4 a share 
2 Billion BO is $8 a share 
3 Billion BO is $12 a share 
 
Consider Novartis buyout of MorphoSys at roughly 2.9 billion on Feb. 8, 2024, and all at once the above numbers start looking reasonable.  It is 5 cents (US) a share right now.  I don&#39;t think with this type of analogy  it can be proven I am pumping the stock, but in fact advising to a possible ground floor price opportunity.  (All IMO).

NewMexicats

Guillaume

d. b.

S. Barry Hamdani

StockTwits Web

Biovaxys Technology Corp

 has some impressive partners and portfolio after the recent acquisition.   
 
I can't imagine this company not being a prime candidate for buyout in the next twelve months.  With 250-275 million shares (including outstanding warrants), below is what buyout prices per share in US dollars is: 
 
Levels that are a joke IMO 
100 million BO is 40 cents a share 
250 million BO is $1 a share 
500 million BO is $2 a share 
 
Realistic Levels 
750 million BO is $3 a share 
1 Billion BO is $4 a share 
2 Billion BO is $8 a share 
3 Billion BO is $12 a share 
 
Consider Novartis buyout of MorphoSys at roughly 2.9 billion on Feb. 8, 2024, and all at once the above numbers start looking reasonable.  It is 5 cents (US) a share right now.  I don't think with this type of analogy  it can be proven I am pumping the stock, but in fact advising to a possible ground floor price opportunity.  (All IMO).

Einstein

Here is the article referencing the Novartis buyout.  https://www.biopharminternational.com/view/novartis-to-acquire-morphosys-for-roughly-2-9-billion

Through a €2.7 billion (US$2.9 billion) acquisition of MorphoSys, Novartis will get pelabresib, a late-stage drug candidate in development for cancer treatment.

BioPharm International

Novartis to Acquire MorphoSys for Roughly $2.9 Billion

Here is the article referencing the Novartis buyout.  

@FLArnot Love your post! Thanks. I was planning on waiting more than one year, but hey, if something happens before that, I&#39;m quite happy!

StockTwits For Android 

 Love your post! Thanks. I was planning on waiting more than one year, but hey, if something happens before that, I'm quite happy!

@Johndoe1979 Complete Speculation: 
Follow the timeline: 
1. Late 2022 BIOVAXS most like entered talks with TAET software 
2. March 2023 they acquire TAET. 
3. I believe between committing to TAET and acquiring it, they were approached by Maxim group to entertain a deal for IMV.  IMV went from 77 Mil Cap in Aug 22 to 23 Mil in Jan 23, below the amount they owed. 
4. April 2023 they have a board change. 
5. April 2023 they officially partner with Maxim. 
6. June 2023 they sell TAET after 90 days (setting up for the IMV adventure) 
7. IMV has serious issues in April that starts the path to Sept. and court decisions. 
8. Sept. IMV accepts offer from its secured lenders. 
9. Oct to Nov BIOVAXS fails to stay on the CSE due to books (they were busy). 
10. Dec. acquisition is announced 
11. Jan. LOI  
12. Feb. DA and closure  
13. Debt was settled in the acquisition

 Complete Speculation: 
Follow the timeline: 
1. Late 2022 BIOVAXS most like entered talks with TAET software 
2. March 2023 they acquire TAET. 
3. I believe between committing to TAET and acquiring it, they were approached by Maxim group to entertain a deal for IMV.  IMV went from 77 Mil Cap in Aug 22 to 23 Mil in Jan 23, below the amount they owed. 
4. April 2023 they have a board change. 
5. April 2023 they officially partner with Maxim. 
6. June 2023 they sell TAET after 90 days (setting up for the IMV adventure) 
7. IMV has serious issues in April that starts the path to Sept. and court decisions. 
8. Sept. IMV accepts offer from its secured lenders. 
9. Oct to Nov BIOVAXS fails to stay on the CSE due to books (they were busy). 
10. Dec. acquisition is announced 
11. Jan. LOI  
12. Feb. DA and closure  
13. Debt was settled in the acquisition

@FLArnot @Johndoe1979 one issue that could screw up biov and thus us, is maxim group.
The only thing those clowns are good for is target practice

 one issue that could screw up biov and thus us, is maxim group.
The only thing those clowns are good for is target practice